The Paradigm Shift from Traditional Scientific Platforms to Integrated Communications Plans
In the rapidly evolving biopharma landscape, the approach to scientific communications is undergoing a significant transformation. The shift from traditional scientific platforms to integrated communications plans (ICPs) is becoming increasingly crucial for ensuring cohesive and impactful messaging. This article delves into the components, implementation, and benefits of an ICP tailored for the biopharma industry, addressing the challenges of fragmented messaging and the need for a unified communication strategy...
Read MoreTop Stories
The Paradigm Shift from Traditional Scientific
In the rapidly evolving biopharma landscape, the approach to...
It’s Never Too Soon: How and When to
Engagement with Medical Affairs is critical at every...
Celebrating Health Literacy Month 2024:
October is Health Literacy Month, a reminder of the...
Filter
Bringing New Devices to Market under the EU MDR
With the MDR coming into effect, the manufacturers should plan and construct their strategy to...
Role of Scientific Communication and Medical Professionals in Combating Vaccine Hesitancy
Read an insightful discussion from the latest ISMPP conference on how science communication and medical...
Digital Therapeutics and Medical Communications: Are We Ready?
Digital Therapeutics are very new and complex, and their use will involve changing standard therapeutic...
EU MedTech Summit 2020: Highlights and Top 3 Takeaways
How is the MedTech industry gearing up for the EU-MDR? Here are some key takeaways...
EU MDR: Increasing Expectations for Clinical Evidence
While the global medical devices industry is closely watching how the European Union (EU) Medical...